ArticleOncology letters2025

Longitudinally extensive transverse myelitis after pembrolizumab and lenvatinib therapy for a rare subtype of renal cell carcinoma: A case report.

Mateusz Piętak et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.